Sign in
Taking people in United StatesNo phase

Registry tracking frailty and aging in older adults with blood cancers

Records frailty and aging health in people aged 50 and older with blood cancers.

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the site
Trial code
Registry title
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Status
Recruiting
People taking part
5,000 people, planned
Started
21 Jul 2020
Expected to end
31 Dec 2027
Type of study
Observational
Record updated
8 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 50 or older with a biopsy-proven blood cancer who have appointments at UAB. It builds a registry to learn about frailty and age-related problems.

Age
50 years or older
Sex
All sexes can join. No exclusions based on gender, ethnicity or race.
Disease stage
A biopsy-proven blood cancer, such as multiple myeloma, AL amyloidosis, Waldenstrom's Macrogloblunemia, Hodgkin or Non-Hodgkin lymphoma, myelodysplastic syndromes, myeloproliferative neoplasm, or acute or chronic myeloid or lymphoid leukemia.

Main reasons for not taking part

  • Under 50 years old
  • Does not read or speak English

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients are ≥50 years of age
  • Patients have a biopsy proven diagnosis of Hematologic Malignancy (Multiple Myeloma, AL Amyloidosis, Waldenstrom's Macrogloblunemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Myelodysplastic syndromes, Myeloproliferative Neoplasm, Acute/Chronic Myeloid Leukemia, Acute/Chronic Lymphoid Leukemia)
  • Patients have appointments at UAB including if they are an inpatient or other clinic locations

Who cannot take part

  • Individuals who are <50 years old
  • Patients who do not read and/or speak English will not be eligible for this study as many of the questionnaires are not validated in other languages. No exclusions will be made based on gender, ethnicity or race

Where in United States

  • Kirklin Clinic of UAB HospitalBirmingham, United StatesContact: Smith Giri, Dr.Taking people

About the trial

What the trial wants to find out

The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
Plain-language title
Registry tracking frailty and aging in older adults with blood cancersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 December 2025